Mozart Therapeutics

Series-A
mozart-tx.com Biotech & Healthcare
Total Funding $25M
Latest Round $25M Series-A
Last Announced Jun 7, 2023
Investors Undisclosed
Decision Makers 6 Verified

About Mozart Therapeutics

Mozart Therapeutics is developing CD8 Treg modulators for the treatment of autoimmune and inflammatory diseases.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website mozart-tx.com
Domain Registered Date Jun 24, 2020

Social & Network Presence

X / Twitter Profile @Mozart_tx (30 followers) Created on Oct 2021
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $25,000,000 · Series-A

    fundraisingfox.com

  2. Capital Raise

    Series-A announced

    fundraisingfox.com

  3. Milestone

    X account created (@Mozart_tx)

    30 followers

  4. Milestone

    Website domain registered

    mozart-tx.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Mozart Therapeutics.

Funding History

2 Rounds
Series-A · Jun 7, 2023
Series-A · Oct 26, 2021

Founders & Leadership

5

Calvin Kuo

Scientific Co-Founder

Work email & phone locked Unlock →

Gerald T. Nepom

Scientific Co-Founder

Work email & phone locked Unlock →

K. Christopher Garcia

Scientific Co-Founder

Work email & phone locked Unlock →

Mark Davis

Scientific Co-Founder

Work email & phone locked Unlock →

Michael Rosenblum

Scientific Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts